Takeda Announces $900-M Restructuring Plan 
By

By
Takeda has announced a multi-year $900-million restructuring plan focused on organizational agility, spending efficiencies, and leveraging the company’s capabilities in data, digital and technology (DD&T). The program, which was approved…

Supplier News: Solvias, GRAM & Sharp 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Solvias, Grand River Aseptic Manufacturing and Sharp.   Biologics Manufacturing * Solvias To Build Biologics Testing Center * ExcellGene, Cytovance Partner for Cell-Line Development Formulation Development/Drug…

Partnering News: Novartis, BMS, BI, AstraZeneca & More 
By

By
A roundup of bio/pharmaceutical partnering news from Novartis/PeptiDream, BMS/Repertoire, Ipsen/Skyhawk, Boehringer Ingelheim/Ochre Bio, Astellas/Poseida Therapeutics, Novo Nordisk/Metaphore Biotechnologies, AstraZeneca/Cellectis, Regeneron/Mammoth Biosciences, GSK/BioVersys, Takeda/Astellas, Eli Lilly and Company/5 Prime Sciences, Bayer/Evotec,…

Global Briefs: Pfizer, Kenvue, Novo Nordisk & More 
By

By
A roundup of news from Pfizer, Kenvue, Novo Nordisk/Alkermes, Incyte/Escient Pharmaceuticals and Evotec. Highlights below.   Restructuring News * Kenvue, J&J Consumer Healthcare Spinout, Announces RestructuringMfg News * Novo Nordisk Completes $91-M Acquisition…

Ono Pharmaceutical To Acquire Deciphera Pharmaceuticals for $2.4 Bn 
By

By
Ono Pharmaceutical, an Osaka, Japan-based bio/pharmaceutical company, has agreed to acquire Deciphera Pharmaceuticals, a Waltham, Massachusetts-based bio/pharmaceutical company, for $2.4 billion.  The pending acquisition would add to Ono’s oncology operations…

Novartis To Acquire Mariana Oncology in $1.75-Bn Deal 
By

By
Novartis has agreed to acquire Mariana Oncology, a Watertown, Massachusetts-based bio/pharmaceutical company developing radioligand therapies (RLTs) to treat cancers, in a deal worth up to $1.75 billion ($1 billion upfront…

AbbVie Breaks Ground on $160-M R&D Building at Site in Germany
By

By
AbbVie has broken ground on a new central research building in Ludwigshafen, Germany, by investing approximately EUR 150 million ($160 million) in its second largest R&D location worldwide.   A research…

Emergent BioSolutions Announces Restructuring Plan 
By

By
Emergent BioSolutions, a Gaithersburg, Maryland-based specialty bio/pharmaceutical company and contract manufacturer, has announced the next phase of a new operational plan that consolidates operations, closes several manufacturing facilities, and restructures…

Supplier News: Adare Pharma Solutions, Cytiva, PCI Pharma Services & PharmaLogic 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Adare Pharma Solutions, Cytiva, PCI Pharma Services, and PharmaLogic.   Chemicals/Chemical API Manufacturing * PharmaLogic Opens Radiopharmaceutical Mfg Facility   Biologics Manufacturing * Cytiva Adds New…

Novartis Nominates Former BMS CEO & Executive Chairman as New Chair
By

By
Novartis has proposed Dr. Giovanni Caforio, ex-CEO and Executive Chairman of Bristol Myers Squibb, as Chair of the company’s Board of Directors.  The election to decide the next chair of Novartis’…